Literature DB >> 12057136

Locally advanced head and neck cancer.

M S Kies1, C L Bennett, E E Vokes.   

Abstract

The simultaneous administration of chemotherapy and radiation has produced a significant impact on the treatment of advanced squamous cell carcinomas of the head and neck. Although no single regimen has emerged as the "standard" approach, recent trials have consistently demonstrated the superiority of combined treatment programs over radiotherapy alone for local tumor control and overall survival. Moreover, multimodal treatment has emerged with important ancillary goals of organ preservation, improved cosmesis, and enhancement of quality of life. With improving survival in all stages of disease, much attention can be given to identifying effective measures to reduce the risk of metachronous primary cancers in this high-risk group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12057136     DOI: 10.1007/s11864-001-0012-x

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  24 in total

1.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.

Authors:  G Calais; M Alfonsi; E Bardet; C Sire; T Germain; P Bergerot; B Rhein; J Tortochaux; P Oudinot; P Bertrand
Journal:  J Natl Cancer Inst       Date:  1999-12-15       Impact factor: 13.506

Review 2.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

3.  Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.

Authors:  B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vaskovic; L Tadic
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

4.  A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer.

Authors:  N K Gupta; R C Pointon; P M Wilkinson
Journal:  Clin Radiol       Date:  1987-11       Impact factor: 2.350

5.  Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study.

Authors:  T C Lo; A L Wiley; F J Ansfield; J H Brandenburg; H L Davis; F F Gollin; R O Johnson; G Ramirez; H Vermund
Journal:  AJR Am J Roentgenol       Date:  1976-02       Impact factor: 3.959

6.  Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.

Authors:  M S Kies; D J Haraf; I Athanasiadis; M Kozloff; B Mittal; H Pelzer; A W Rademaker; B Wenig; R R Weichselbaum; E E Vokes
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

7.  Combined bleomycin and radiotherapy in oral cancer.

Authors:  V Shanta; S Krishnamurthi
Journal:  Clin Radiol       Date:  1980-09       Impact factor: 2.350

8.  Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.

Authors:  G P Browman; C Cripps; D I Hodson; L Eapen; J Sathya; M N Levine
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

9.  Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy.

Authors:  W K Hong; R H Bromer; D A Amato; S Shapshay; M Vincent; C Vaughan; B Willett; A Katz; J Welch; S Fofonoff
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

10.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

Authors:  D M Brizel; M E Albers; S R Fisher; R L Scher; W J Richtsmeier; V Hars; S L George; A T Huang; L R Prosnitz
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

View more
  5 in total

Review 1.  Deep learning approaches for automated classification and segmentation of head and neck cancers and brain tumors in magnetic resonance images: a meta-analysis study.

Authors:  Samireh Badrigilan; Shahabedin Nabavi; Ahmad Ali Abin; Nima Rostampour; Iraj Abedi; Atefeh Shirvani; Mohsen Ebrahimi Moghaddam
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-03-05       Impact factor: 2.924

2.  Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.

Authors:  Anuradha Soundararajan; Gerald D Dodd; Ande Bao; William T Phillips; Linda M McManus; Thomas J Prihoda; Beth A Goins
Journal:  Radiology       Date:  2011-10-24       Impact factor: 11.105

3.  [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.

Authors:  Anuradha Soundararajan; Ande Bao; William T Phillips; Ricardo Perez; Beth A Goins
Journal:  Nucl Med Biol       Date:  2009-05-07       Impact factor: 2.408

4.  Convolutional neural networks for head and neck tumor segmentation on 7-channel multiparametric MRI: a leave-one-out analysis.

Authors:  Lars Bielak; Nicole Wiedenmann; Arnie Berlin; Nils Henrik Nicolay; Deepa Darshini Gunashekar; Leonard Hägele; Thomas Lottner; Anca-Ligia Grosu; Michael Bock
Journal:  Radiat Oncol       Date:  2020-07-29       Impact factor: 3.481

5.  PEGylated liposome-encapsulated rhenium-188 radiopharmaceutical inhibits proliferation and epithelial-mesenchymal transition of human head and neck cancer cells in vivo with repeated therapy.

Authors:  Chun-Yuan Chang; Chao-Cheng Chen; Liang-Ting Lin; Chih-Hsien Chang; Liang-Cheng Chen; Hsin-Ell Wang; Te-Wei Lee; Yi-Jang Lee
Journal:  Cell Death Discov       Date:  2018-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.